Open AccessCost-Effectiveness of Adding Cardiac Resynchronization Therapy to an Implantable Cardioverter-Defibrillator Among Patients With Mild Heart Failure
Author(s) -
Christopher Y. Woo,
Erika Strandberg,
Michelle Schmiegelow,
Allison Pitt,
Mark A. Hlatky,
Douglas K Owens,
Jeremy D. Goldhaber-Fiebert
Publication year - 2015
Publication title -
annals of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.839
H-Index - 390
eISSN - 1539-3704
pISSN - 0003-4819
DOI - 10.7326/m14-1804
Subject(s) - medicine , cardiac resynchronization therapy , heart failure , ejection fraction , implantable cardioverter defibrillator , cardiology , cost effectiveness , qrs complex , life expectancy , population , emergency medicine , risk analysis (engineering) , environmental health
Cardiac resynchronization therapy (CRT) reduces mortality and heart failure hospitalizations in patients with mild heart failure.